Redburn Atlantic analyst Jamie Clark initiated coverage of Lonza (LZAGY) with a Buy rating and CHF 650 price target Lonza, as the world’s largest contract development and manufacturing organization, has long-term contracted revenues and high barriers to entry, while demand for biologic capacity is booming, the analyst tells investors. The firm sees the material investment Lonza has made in expanding its capacity between 2024 and 2026 driving high-teens biologics revenue growth and a 2024-27 core EPS compound annual growth rate of 19% with additional long-term upside catalysts, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LZAGY:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue